Why Is Minority Participation So Low in MS Drug Trials?
The lack of minority participation in MS clinical trials can probably be blamed on a variety of factors. “When trials…
New MS Treatment Study Focuses on Black and Hispanic Americans
The first study of its kind, CHIMES will look at how the drug Ocrevus works in minority groups that are…
Stuart Schlossman
Learn about ANTIDOTE for Clinical Trials
What are Clinical Trials? Clinical trials are scientific studies that test the safety and effectiveness of new treatments for MS…
Stuart Schlossman
Participation is needed in Research Studies
Information showing below is provided by The National MS Society NOTE: The COVID-19 pandemic may affect the status of the…
Stuart Schlossman
MS Trial Alert: Investigators Recruiting for Two Phase 3 Trials of Experimental Evobrutinib in Relapsing MS
Note: Without participants in research studies, MS research would come to a standstill. Read more here. February 16, 2021 SUMMARY: Investigators…
Stuart Schlossman
Clinical trial opportunity for individuals with multiple sclerosis
Multiple sclerosis (MS) is a condition that causes damage to the central nervous system. 85% of people diagnosed with MS…
Stuart Schlossman
